One in every three FDA-approved drugs targets a single superfamily of receptors dotting the surfaces of human cells.
Eli Lilly’s chief scientist on new obesity drug data, gene editing, and a potential new heart drug
PHILADELPHIA — In a sense, the annual meeting of the American Heart Association wasn’t a huge one for Eli Lilly. Its biggest news was about